Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDowning Renewa. Regulatory News (DORE)

  • This share is currently suspended. It was suspended at a price of 102.00
  • There is currently no data for DORE

Form8.3DOWNINGRENEWABLES&INFRASTRUCTURETRUSTPLC/FU

30 Jul 2025 13:29

RNS Number : 2359T
Barclays PLC
30 July 2025
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DOWNING RENEWABLES & INFRASTRUCTURE TRUST PLC/FUND

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

29 Jul 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

2,321,346

1.36%

0

0.00%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

0

0.00%

2,321,346

1.36%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

2,321,346

1.36%

2,321,346

1.36%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1p ordinary

Sale

58

1.0150 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1p ordinary

SWAP

Decreasing Short

58

1.0150 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

30 Jul 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETPKKBBBBKDAON
Date   Source Headline
6th Aug 20245:37 pmRNSDirector/PDMR Shareholding
6th Aug 20245:29 pmRNSTransaction in Own Shares
5th Aug 20245:23 pmRNSTransaction in Own Shares
2nd Aug 20245:31 pmRNSTransaction in Own Shares
1st Aug 20245:23 pmRNSTransaction in Own Shares
1st Aug 202410:10 amRNSTotal Voting Rights
31st Jul 20243:37 pmRNSTransaction in Own Shares
26th Jul 20245:18 pmRNSTransaction in Own Shares
23rd Jul 20242:50 pmRNSTransaction in Own Shares
19th Jul 20243:31 pmRNSTransaction in Own Shares
11th Jul 20244:35 pmRNSTransaction in Own Shares
8th Jul 20247:00 amRNSAppointment of Non-Executive Director
5th Jul 20244:48 pmRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSDORE Hydro Pre-Qualifies For FCR Markets in Sweden
1st Jul 20242:55 pmRNSTotal Voting Rights
28th Jun 20245:25 pmRNSTransaction in Own Shares
27th Jun 20245:43 pmRNSTransaction in Own Shares
26th Jun 20245:29 pmRNSTransaction in Own Shares
25th Jun 20245:26 pmRNSTransaction in Own Shares
24th Jun 20245:27 pmRNSTransaction in Own Shares
20th Jun 20245:25 pmRNSTransaction in Own Shares
19th Jun 20245:38 pmRNSTransaction in Own Shares
18th Jun 20245:48 pmRNSTransaction in Own Shares
17th Jun 20245:37 pmRNSTransaction in Own Shares
14th Jun 20245:31 pmRNSTransaction in Own Shares
13th Jun 20245:58 pmRNSTransaction in Own Shares
10th Jun 20247:00 amRNSNet Asset Value and Operational Update
10th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20243:16 pmRNSResult of AGM
3rd Jun 20242:54 pmRNSTotal Voting Rights
22nd May 20247:00 amRNSDividend Declaration
20th May 202412:27 pmRNSAnnual Overview from QuotedData
13th May 20247:00 amRNSNotice of Capital Markets Event
2nd May 20244:58 pmRNSDirector/PDMR Shareholding
1st May 20245:16 pmRNSTransaction in Own Shares
1st May 202411:05 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSNotice of AGM
24th Apr 20245:10 pmRNSTransaction in Own Shares
22nd Apr 20245:37 pmRNSTransaction in Own Shares
19th Apr 20245:23 pmRNSTransaction in Own Shares
18th Apr 20245:31 pmRNSTransaction in Own Shares
16th Apr 20244:51 pmRNSTransaction in Own Shares
15th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 20245:30 pmRNSTransaction in Own Shares
11th Apr 20247:00 amRNSAnnual Financial Report
9th Apr 20245:31 pmRNSTransaction in Own Shares
8th Apr 20247:00 amRNSIcelandic Hydro Plant Enters New Long-Term PPA
5th Apr 20247:02 amRNSInvestor Presentation via Investor Meet Company
5th Apr 20247:00 amRNSAnnual Results - New Date of Publication
3rd Apr 20245:41 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.